Thomas Van Cann
Impact in
-
- Bone and Joint Diseases
- Oncology top 10%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Vascular Tumors and Angiosarcomas
Papers in
- Oncology 9
- Vascular Tumors and Angiosarcomas 5
- Cancer Diagnosis and Treatment 3
- Bone health and treatments 3
-
- Sarcoma Diagnosis and Treatment 6
- Co-authors
- Patrick Schöffski (10 shared papers)Agnieszka Woźniak (5 shared papers)Raf Sciot (6 shared papers)Maria Dêbiec‐Rychter (5 shared papers)Jasmien Cornillie (5 shared papers)Herlinde Dumez (3 shared papers)Benoit Beuselinck (3 shared papers)Ludo Willems (2 shared papers)
- Journals
- British Journal of Cancer (1 paper)Journal of Clinical Oncology (1 paper)Sarcoma (1 paper)The Lancet Respiratory Medicine (1 paper)Supportive Care in Cancer (1 paper)
- Partner nations
- BelgiumNetherlandsUnited Kingdom
In The Last Decade
Thomas Van Cann
11 papers receiving 365 citations
Peers
Comparison fields: 5 of 43
- Orthopedics and Sports Medicine 96
- Oncology 243
- Rheumatology 99
- Pulmonary and Respiratory Medicine 154
- Gastroenterology 13
Countries citing papers authored by Thomas Van Cann
This map shows the geographic impact of Thomas Van Cann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Van Cann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Van Cann more than expected).
Fields of papers citing papers by Thomas Van Cann
This network shows the impact of papers produced by Thomas Van Cann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Van Cann. The network helps show where Thomas Van Cann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Van Cann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 123 | |
| 2 | 2012 | 86 | |
| 3 | 2017 | 42 | |
| 4 | 2017 | 40 | |
| 5 | 2016 | 28 | |
| 6 | 2017 | 20 | |
| 7 | 2019 | 15 | |
| 8 | 2021 | 6 | |
| 9 | 2017 | 4 | |
| 10 | 2018 | 2 | |
| 11 | 2017 | 2 |
About Thomas Van Cann
Thomas Van Cann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 11 papers that have together received 368 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Vascular Tumors and Angiosarcomas (5 papers), Cancer Diagnosis and Treatment (3 papers), Bone health and treatments (3 papers), Cardiac tumors and thrombi (3 papers), Soft tissue tumors and treatment (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Bone and Joint Diseases (2 papers). The work is most often cited by research in Orthopedics and Sports Medicine (96 citations), Oncology (243 citations), Rheumatology (99 citations), Pulmonary and Respiratory Medicine (154 citations) and Gastroenterology (13 citations). Thomas Van Cann has collaborated with scholars based in Belgium, Netherlands and United Kingdom. Frequent co-authors include Patrick Schöffski, Agnieszka Woźniak, Raf Sciot, Maria Dêbiec‐Rychter, Jasmien Cornillie, Herlinde Dumez, Benoit Beuselinck, Ludo Willems, Philip R. Debruyne and Michael Leahy. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Sarcoma, The Lancet Respiratory Medicine and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.